Genus (GNS) Receives “Hold” Rating from Liberum Capital

Genus (LON:GNS)‘s stock had its “hold” rating restated by stock analysts at Liberum Capital in a report issued on Monday. They currently have a GBX 2,400 ($33.16) target price on the stock. Liberum Capital’s target price indicates a potential upside of 1.87% from the company’s previous close.

Several other analysts also recently commented on the stock. Berenberg Bank reaffirmed a “hold” rating and set a GBX 1,800 ($24.87) target price on shares of Genus in a report on Thursday, March 1st. Peel Hunt reissued a “buy” rating and issued a GBX 2,600 ($35.92) price objective on shares of Genus in a report on Wednesday, February 28th. N+1 Singer reissued a “buy” rating on shares of Genus in a report on Thursday, November 16th. Finally, Kepler Capital Markets reissued a “hold” rating and issued a GBX 2,353 ($32.51) price objective on shares of Genus in a report on Wednesday, November 15th. Four analysts have rated the stock with a hold rating and two have issued a buy rating to the company. The company currently has an average rating of “Hold” and an average target price of GBX 2,242.17 ($30.98).

Shares of Genus (GNS) opened at GBX 2,356 ($32.55) on Monday. The company has a market cap of $1,450.00 and a PE ratio of 4,207.14. Genus has a twelve month low of GBX 1,652 ($22.82) and a twelve month high of GBX 2,597 ($35.88).

In other Genus news, insider Stephen Wilson sold 1,625 shares of the business’s stock in a transaction dated Tuesday, December 19th. The shares were sold at an average price of GBX 2,552 ($35.26), for a total value of £41,470 ($57,294.83). Also, insider Karim Bitar sold 32,292 shares of the business’s stock in a transaction dated Thursday, December 28th. The shares were sold at an average price of GBX 2,511 ($34.69), for a total transaction of £810,852.12 ($1,120,270.96).

TRADEMARK VIOLATION NOTICE: This news story was reported by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this news story on another publication, it was illegally stolen and republished in violation of United States & international copyright & trademark law. The correct version of this news story can be viewed at https://sportsperspectives.com/2018/03/12/genus-gns-receives-hold-rating-from-liberum-capital.html.

Genus Company Profile

Genus plc is an animal genetics company, which provides farmers with genetics that enable them to produce animal protein, in the form of meat and milk. The Company’s segments include Genus PIC, Genus ABS, Genus Asia, and Research and Development. The Genus PIC segment is engaged in porcine sales business, excluding Asia, and serves porcine customers in North America, Latin America and Europe.

Analyst Recommendations for Genus (LON:GNS)

Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply